Target intelligence / Profile preview

Ectodysplasin-A receptor-associated adapter protein (EDARADD)

Target
EDARADD
Molecular classification
Adapter protein, Signaling adaptor (Death domain protein), Other
01

Overview

Ectodysplasin-A receptor-associated adapter protein (EDARADD) is an intracellular signaling adaptor containing a death domain, which couples the ectodysplasin-A receptor (EDAR) to downstream pathways, notably the NF-κB transcription factor cascade[1][3][4]. EDARADD is essential for interpreting signals between embryonic ectoderm and mesoderm, thus regulating development and morphogenesis of structures such as hair follicles, teeth, skin, and sweat glands[1][3]. Mutations in EDARADD disrupt protein-protein interactions necessary for normal signaling, causing various forms of ectodermal dysplasia, primarily hypohidrotic ectodermal dysplasia, characterized by defective hair, teeth, and sweat gland formation[1][4]. EDARADD interacts directly with EDAR, and recruits effectors like TRAF6 and TAB2, activating the IκB kinase complex and promoting cell-specific gene expression during organogenesis[3][4]. No approved drugs currently target EDARADD; its biological role makes it principally a molecular and diagnostic target for genetic disorders of ectodermal differentiation.

Other names
EDAR associated via death domainEDAR-associated death domain proteinProtein crinkled homologCrinkledEDAD_HUMANECTD11AECTD11BED3EDA3ectodysplasia A receptor associated death domain
02

Mechanism of action

no approved drugs target this adapter protein directly; potential mechanism if developed: modulation of EDAR-NF-κB signaling

03

Biological functions

Signal transductionCell proliferationCell differentiationMorphogenesis of ectodermal organs (hair, teeth, skin appendages)NF-κB pathway activation
04

Disease associations

Ectodermal dysplasia (especially hypohidrotic type)Isolated tooth agenesisOther rare developmental disorders of ectodermal origin
05

Safety considerations

Tissue specificity (modulation could affect multiple ectodermal-derived organs)Developmental: targeting could have profound effects on embryonic development and organogenesis
06

Biomarkers

Mutations in EDARADD gene (as genetic diagnostic marker for hypohidrotic ectodermal dysplasia and related phenotypes)

Beyond the preview

Go deeper on Ectodysplasin-A receptor-associated adapter protein (EDARADD).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ectodysplasin-A receptor-associated adapter protein (EDARADD).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call